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Abstract
The majority of diseases in the retina are caused by genetic mutations affecting the development and function of
photoreceptor cells. The transcriptional networks directing these processes are regulated by genes such as nuclear
hormone receptors. The nuclear hormone receptor gene Rev-erb alpha/Nr1d1 has been widely studied for its role in the
circadian cycle and cell metabolism, however its role in the retina is unknown. In order to understand the role of Rev-erb
alpha/Nr1d1 in the retina, we evaluated the effects of loss of Nr1d1 to the developing retina and its co-regulation with the
photoreceptor-specific nuclear receptor gene Nr2e3 in the developing and mature retina. Knock-down of Nr1d1 expression
in the developing retina results in pan-retinal spotting and reduced retinal function by electroretinogram. Our studies show
that NR1D1 protein is co-expressed with NR2E3 in the outer neuroblastic layer of the developing mouse retina. In the adult
retina, NR1D1 is expressed in the ganglion cell layer and is co-expressed with NR2E3 in the outer nuclear layer, within rods
and cones. Several genes co-targeted by NR2E3 and NR1D1 were identified that include: Nr2c1, Recoverin, Rgr, Rarres2,
Pde8a, and Nupr1. We examined the cyclic expression of Nr1d1 and Nr2e3 over a twenty-four hour period and observed that
both nuclear receptors cycle in a similar manner. Taken together, these studies reveal a novel role for Nr1d1, in conjunction
with its cofactor Nr2e3, in regulating transcriptional networks critical for photoreceptor development and function.
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Introduction
Nuclear receptors represent an evolutionarily conserved group
of transcription factors that regulate genes involved in diverse
functions such as homeostasis, reproduction, development,
metabolism and immune response. Nuclear receptors bind to
lipophilic-ligands such as steroid hormones, thyroid hormone,
vitamin D and retinoids, which modulate transcriptional activity
[1–5]. Nuclear receptors also function with co-activators or co-
repressors to activate or repress the transcription of genes involved
in the development and maintenance of specific cell types. In the
mouse retina, nuclear receptors regulate the development and
patterning of many cell types, including photoreceptor cells
consisting of rods (responsible for night vision) and cones
(responsible for color vision and visual acuity). The development
and patterning of cone cells in mice is regulated by the nuclear
receptor thyroid hormone receptor b2( Trb2, Nr1a2b), which
controls the dorsal-to-ventral development and the terminal
differentiation of medium (M)-opsin expressing cone cells [6–7].
Retinoid X receptor gamma (Rxrc) and Retinoic acid-related
orphan receptor beta (Rorb) control the generation of short (S)-
opsin-expressing cones (also referred to as blue cones) [8–9].
RORb also induces rod photoreceptor differentiation by activating
the rod-selective transcription factor Neural retina leucine zipper
(Nrl) [10]. Rod photoreceptor function and survival is also
regulated by the estrogen-related receptor b (Errb) [11].
NR2E3 (mouse Nr2e3) is a nuclear receptor critical for the
development and maintenance of rod and cone photoreceptor
cells, and loss of NR2E3 results in disease. Mutations in human
NR2E3 cause several forms of retinal degeneration including
autosomal recessive enhanced S-cone syndrome [12–13], Gold-
mann-Favre syndrome [14–18], clumped pigmentary retinal
degeneration [14,17], and autosomal dominant and recessive
retinitis pigmentosa [19–21]. Loss of NR2E3 results in a decrease
in rod, long-(L) cone and M-cone function, and hypersensitivity to
blue light, presumably due to an over generation of S-opsin
expressing cone cells [12]. Mice lacking Nr2e3 (Nr2e3
rd7/rd7, rd7)
have supernumerary blue cone cells and slow, progressive loss of
rods and cones [22–23]. In addition, mice lacking a functional
Nr2e3 clinically display retinal spotting observable at eye opening
(postnatal day 14.5), and retinal dysplasia with whorls present at
postnatal day 12.5 [24]. In recent studies, NR2E3 is expressed
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functions as a suppressor of the cone generation program [24].
NR2E3 has been shown to regulate gene networks involved in
photoreceptor development and function, and loss of Nr2e3 causes
mis-regulation of cone and rod genes [25–29].
NR2E3functionswithco-factorssuchasRetCoRandREV-ERB
alpha (NR1D1) to regulate gene expression in the retina [25,30]. In
vitro, NR2E3 forms complexes with NRL, cone rod homeobox
(CRX) and NR1D1 to regulate the expression of the rod
phototransduction genes Rhodopsin and Guanine nucleotide-binding
protein 1 (Gnat1) [25]. Recent studies also demonstrate that Nr1d1 is
up-regulated in rd7 miceduring development and in the adult retina
[29]. These studies also determined that Nr1d1 is a direct target of
NR2E3 by chromatin immunoprecipitation, suggesting that these
factors function in the same transcriptional network [29].
Nr1d1 appears to have a diverse role in regulating gene networks
in many tissue types and several biological processes. Additionally,
activated Nr1d1 is able to function as a monomer or a dimer, and is
capable of repressing or activating gene expression, suggesting that
Nr1d1 has a diverse role in gene regulation [31–33]. Little is known
about the role of Nr1d1 in the mammalian retina, however its
expression has been studied in a variety of tissues including skeletal
muscle, liver, adipose, and eye, with its highest expression in the
eye [3,29,34–38]. Nr1d1 has been widely studied for its role in
transcriptional regulation of processes such as circadian rhythm
and metabolism, with heme functioning as an endogenous ligand
[39–40]. Nr1d1 was first identified as being encoded on the
opposite strand of the thyroid hormone receptor, and was shown
to bind to thyroid hormone receptor response elements, suggesting
a potential role in the Trb2-driven differentiation of M-opsin
expressing cone cells (green cones) [6,41–42]. While the role of
Nr1d1 in the retina is not well understood, recent studies indicate
that it may have a crucial role in retinal development, and
functions in the same transcriptional network as Nr2e3 [29].
In this study, we determined the normal expression pattern of
NR1D1 in the retina, identified co-targets of NR1D1 and NR2E3,
a n dd e t e r m i n e dt h ee f f e c to fl o s so fNr1d1 in the retina. We
determined that NR1D1 and NR2E3 have a similar expression
profile, and thatNR1D1 isexpressed in retinalprogenitor cells during
development, and in ganglion cells and photoreceptors of the adult
retina. We further identified several genes involved in phototransduc-
tion, signaling and development that are co-targeted by NR1D1 and
NR2E3, in addition to genes that were individually targeted by either
nuclear receptor. Acute knockdown of Nr1d1 resulted in retinal
abnormalities such as pan-retinal spotting and decreased response to
light. Thesestudies highlight an important rolefor Nr1d1 in the retina
and in gene regulation in concert with Nr2e3.
Results
Rev-erb alpha/NR1D1 is expressed in the developing and
adult retina
Quantitative RT-PCR shows that Nr1d1 is first expressed at
embryonic day 18.5 with increasing expression in the adult retina
(Figure 1 A). The onset of Nr2e3 expression is also embryonic day
18.5, with a peak in expression at postnatal day 6.5 (Figure 1 A).
Because Nr1d1 has been studied for its role in circadian rhythm,
we examined the expression of Nr1d1 and Nr2e3 over a twenty-four
hour period (8 am-8 am). Both Nr1d1 and Nr2e3 mRNAs showed
a cycling pattern with a peak of expression at 4 pm (Figure 1 B).
To determine the localization of NR1D1 protein in the mouse
retina, we first performed Western blotting to confirm antibody
specificity. NR1D1 protein (67 kD) was detected by Western blot
in C57BL/6 (B6) postnatal day 30.5 retinal lysate (Figure 1 C).
During development at embryonic day 18.5, NR1D1 protein was
expressed in the outer neuroblastic layer of the retina where
developing post-mitotic photoreceptors and retinal progenitors
reside (Figure 2 A, B, C, D, E, F). NR1D1 co-localized with
progenitor cell marker Visual system homeobox 2 (CHX10), and
with NR2E3 during development (Figure 2 C, F). In the adult
retina, NR1D1 was predominantly expressed in the outer nuclear
layer, where rod and cone cells reside, and also localized to the
ganglion cell layer (Figure 2 G).
Loss of Rev-erb alpha/NR1D1 results in pan-retinal
spotting, and a decrease in retinal response to light
Loss of NR1D1 expression in the retina was evaluated using
small hairpin (sh)RNA delivery by in vivo electroporation.
Efficiency of gene silencing was first confirmed in vitro by
quantitative RT-PCR (Figure S1). shRNA constructs were injected
subretinally into neonate B6 eyes, and in vivo electroporation was
used to transfect DNA into retinal cells. Mice were aged to
postnatal day 30.5 for clinical, functional and histological analysis.
Clinically, Nr1d1 knockdown at postnatal day 0.5 produced pan-
retinal spotting of the fundus (Figure 3 I A). Delivery of shRNA
directed against crystallin Aa (Cryaa) resulted in lens opacity
Figure 1. Nr1d1 is expressed in the developing and adult retina. A: Expression of Nr1d1 and Nr2e3 in the developing retina. Nr1d1 and Nr2e3
expression begin at embryonic day (E) 18.5 with expression persisting into the adult retina. Nr2e3 expression peaks at postnatal day (P) 6 and
decreases into the adult retina, while the expression of Nr1d1 increases into the adult retina. B: Cyclic expression of Nr1d1 and Nr2e3 in the adult
retina. The cyclic expression pattern of Nr1d1 and Nr2e3 show a peak in expression of both nuclear receptors at 4 pm. Bar indicates when lights are
on and off during the 12 hour light-dark cycle. Quantitative RT-PCR values corrected to fit chart scale. n=3. C: Western blot performed with retinal
lysates depicting NR1D1 protein at the expected size of 67 kDa (red). Beta actin was used as a control (green). MWM: molecular weight marker.
doi:10.1371/journal.pone.0017494.g001
Transcriptional Regulation by Nr1d1 and Nr2e3
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17494(Figure 3 I B). A normal fundus was observed in mice injected with
the empty vector control (Figure 3 I C). Functionally, mice injected
with shNr1d1 had 50% lower response from photoreceptor cells
and second order neurons in both light-adapted (photopic- to test
cone function) and dark-adapted (scotopic- to test rod function)
conditions (Figure 3 II). Histological evaluation with hematoxylin
and eosin staining on shNr1d1-injected mice at postnatal day 30.5
did not reveal any gross histological abnormalities (Figure 4), as are
present with loss of Nr2e3. To identify abnormalities in gene
expression, we examined shNr1d1-injected retinas with retinal cell
type-specific markers at postnatal day 30.5 (Figure 5). This did not
reveal any marked abnormality in abundance and distribution for
any particular cell type within the retina.
Transcriptional networks co-targeted by NR1D1 and
NR2E3 are involved in phototransduction, signaling, and
gene regulation
Microarray analysis was used to identify differentially expressed
genes between B6 and rd7 mice. The time points of embryonic day
18.5 and postnatal day 30.5 were selected as the period in which
Nr2e3expression begins,andasanadult time pointinwhichNr2e3is
expressed. Microarray results were confirmed by quantitative RT-
PCR (Table S1). Recently identified target genes of NR2E3 [29], or
genes identifiedas differentially expressed between wild typeB6 and
mutant rd7 retinas by microarray analysis, were evaluated by
chromatin immunoprecipitation to identify genes that are co-
targeted by both NR1D1 and NR2E3. Chromatin immunoprecip-
itation was conducted with anti-NR1D1 and anti-NR2E3 antibod-
ies in parallel, and samples were analyzed by quantitative RT-PCR
to identify potential co-targets (Figure 6). At embryonic day 18.5,
the potential regulatory regions of a total of eight out of 31 genes
(,25%) were bound by NR1D1, NR2E3 or both nuclear receptors,
and at postnatal day 30.5 six out of 36 genes (,18%) werepositively
targeted by one or both nuclear receptors. The genes targeted by
NR1D1 and NR2E3 at embryonic day 18.5 are involved in:
phototransduction (Interphotoreceptor retinoid-binding protein
(Irbp), Retinal G Protein coupled receptor (Rgr), Recoverin (Rcvn),
Rhodopsin); cell differentiation (RAR-related orphan receptor C
(Rorg/c)); signaling (retinoic acid receptor responder protein 2
(Rarres2)); transcriptional regulation (nuclear receptor subfamily 2,
group C, member 1 (Nr2c1)); or are novel (Bc7393). Nr2c1, Rarres2,
RcvnandRgrwereco-targeted byNR1D1 and NR2E3atembryonic
day 18.5. Bc7393 was targeted by NR2E3 alone, while Irbp, Rorg/c
and Rhodopsin were targeted by NR1D1 alone. The genes targeted
by NR1D1 and NR2E3 in the adult retina are involved in: cell
growth (Nuclear protein one (Nupr1)), phototransduction (phospho-
diesterase 8A (Pde8a)), signaling (signal transducer and activator of
transcription 1 (Stat1)), transcription (myocyte enhancer factor 2C
(Mef2c)), or novel retinal function (otopetrin 3 (Otop3), olfactomedin
1( Olfm1)). Nupr1 and Pde8a were co-targeted by NR1D1 and
NR2E3;Mef2c, Otop3 and Stat1 were targeted by NR1D1 alone; and
Olfm1 by NR2E3 alone.
Figure 2. NR1D1 co-localizes with NR2E3 in the developing and adult retina. Immunohistochemical analysis shows NR1D1 localized to the
outer neuroblastic layer (ONBL) and inner neuroblastic layer (INBL) in the embryonic day (E) 18.5 retina (A–C, D–F). A. NR1D1, B. CHX10, C. Merge +
DAPI, D: NR1D1, E. NR2E3, F: Merge + DAPI. NR1D1 co-localized with progenitor cell markers CHX10 and NR2E3 (C, F). In the adult retina NR1D1 was
expressed in the ONL, and GCL. G. NR1D1, H: NR2E3, I: Merge + DAPI. ONL: outer nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, IPL:
inner plexiform layer, GCL: ganglion cell layer. Scale bar =50 mm.
doi:10.1371/journal.pone.0017494.g002
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phototransduction genes
To determine the transcriptional activity of NR1D1 and
NR2E3 on the potential regulatory regions characterized by
chromatin immunoprecipitation, we cloned these sequences, as
well as proximal promoter regions of the respective genes into a
luciferase reporter plasmid and tested them in HEK293T cells. We
tested the individual transcriptional activity of NR1D1 and
NR2E3, as well as their function in a gene complex with
photoreceptor-specific transcription factor CRX, and rod-specific
Figure 3. Injection with shNr1d1 results in pan-retinal spotting and reduced response to light in scotopic (dark-adapted) and
photopic (light-adapted) experiments. Mice were injected at postnatal day (P) 0.5 and aged to P30.5 for clinical and functional phenotyping. I:
shNr1d1 (A) produced pan-retinal spotting visible on the fundus. Injection with shCryaa (B) resulted in lens opacity. Vector only injections (C) resulted
in no visible fundus phenotype. II: Graphic representation of scotopic electroretinogram testing the function of rod cells, and photopic
electroretinogram testing the function of cone cells, reveled that shNr1d1 reduced the response to light by 50% compared with controls. Responses
from photoreceptor cells and second order neurons were affected. shNr1d1 n=3, B6 control n=5. Statistical significance of a two-tailed unpaired t-
test are shown as: *: p,0.05; **: p,0.01.
doi:10.1371/journal.pone.0017494.g003
Figure 4. Hematoxylin and Eosin staining of shNr1d1 injected retinas does not reveal morphological abnormalities. shNr1d1 and
vector only injected mice were aged to postnatal day 30.5 for analysis by Hematoxylin and Eosin staining. No gross structural abnormalities were
observed in eyes injected with shNr1d1 when compared to vector only controls. RPE: retinal pigmented epithelium, OS: outer segments, IS: inner
segments, ONL: outer nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, IPL: inner plexiform layer, GCL: ganglion cell layer. n=3. Scale
bar =50 mm.
doi:10.1371/journal.pone.0017494.g004
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regulation of the Rhodopsin promoter [25]. The following genes
were tested by luciferase assay: Irbp, Nupr1, Rgr, Rarres2, M-opsin,
(Mw-ops), cone arrestin (Arrestin4), and, as a positive control,
Rhodopsin (Figure 7).
With the exception of the M-opsin proximal promoter that was
activated over three-fold by CRX alone, expression of all other
promoter constructs was significantly induced by NRL alone.
CRX alone repressed the Rarres2 proximal promoter, and
significantly decreased NRL-driven transactivation. Additionally,
concurrent expression of CRX and NRL significantly increased
the activity of promoter constructs. Transcriptional activity of
NR1D1 and NR2E3 depended on the promoter context. For Irbp,
the activity of the putative response site (IrbpRE) was barely
modulated by the expression of transcription factors, but on the
proximal promoter sequence, NR2E3 and NR1D1, alone and
together, activated promoter activity by respectively 2-, 2.9- and
2.6-fold. In addition, CRX/NRL-driven transactivation was
significantly increased to over 3-fold in the presence of both
NR2E3 and NR1D1. The proximal promoter of Rgr was activated
about 4-fold by NR1D1, and this activity could not be repressed
by NR2E3. In presence of NRL, no other transcription factor
Figure 5. Cell type specific markers do not reveal abnormalities in retinal cell number or localization in shNr1d1 injected mice.
Labeling with markers for Blue opsin (blue (S-) opsin expressing cones), Green opsin (green (M-) opsin expressing cones), Rhodopsin (Rod cells),
Parvalbumin (amacrine cells), Calbindin (horizontal cells), and Brn3a (ganglion cells) did not reveal any problems with cell placement, organization or
morphology within the retina when examined at postnatal day 30.5. n=3. Scale bar =50 mm.
doi:10.1371/journal.pone.0017494.g005
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Rhodopsin promoter activity was increased by about 14-fold in
presence of both CRX and NRL. This CRX/NRL-driven
promoter activity was further increased to more than 20-fold in
the presence of NR2E3, and even 35-fold in presence of both
NR2E3 and NR1D1 The 2.6-fold CRX/NRL-driven transactiva-
tion of the Nupr1 response element (NuprRE) was significantly
increased by NR2E3 to 3.6-fold and NR1D1 to 4.2-fold. This
increase in activity was suppressed when NR2E3 was added to the
complex of CRX/NRL/NR1D1. A similar repressive role of
NR2E3 was observed with M-opsin promoter activity. We also
identified that NR1D1 and NR2E3 together were able to drive the
expression of Arrestin4 to a far greater extent than either nuclear
receptor could individually, but that NR1D1 alone was able to
further increase CRX/NRL-driven transactivation from 3.5- to
4.4-fold. These results illustrate that NR2E3 is able to both repress
and activate gene expression and that the presence of co-factors
and additional transcription factors further modulates gene
expression. Furthermore, our results also indicate that NR1D1
serves a role in the activation of many photoreceptor specific
genes.
Discussion
In this study we investigated the role of NR1D1 and NR2E3 in
gene regulation, and the impact of loss of Nr1d1 on the retina. The
implications of these findings aid in our understanding of retinal
development and function, and identify a role for Nr1d1 in the
mammalian retina. The onset of Nr1d1 and Nr2e3 expression
correlated with the end of cone cell generation in mice, a time
period when transcriptional regulation is necessary to prevent the
continued emergence of cones. While loss of Nr2e3 resulted in
continued generation of cone cells, knockdown of Nr1d1 did not
result in the over production of cones. This may indicate that
genetic compensation by Nr2e3 was able to suppress continued
cone generation. Knockdown of Nr1d1 expression did result in
reduction of rod and cone function, suggesting that loss of Nr1d1
alters the development and/or function of these cell types.
Clinically, the pan-retinal spotting produced by loss of Nr1d1
was highly similar to the pan-retinal spotting observed with loss of
Nr2e3 in mice. While loss of Nr1d1 produced a similar clinical
phenotype, histologically we did not observe gross morphological
changes, as are present with loss of Nr2e3. While no retinal whorls
were noted in our shNr1d1-injected mice, there may be additional
ultra-structural abnormalities that were not detected in our studies,
which could explain the observed retinal spotting and functional
deficits. Additionally, our studies only examined injected mice at
P30.5 and lack of Nr1d1 may result in slow or delayed retinal
degeneration. Thus, aging the mice beyond one month may result
in notable histological changes, or a more severe fundus
phenotype. Loss of Nr1d1 may alter, for example, signaling
pathways within photoreceptor cells, therefore limiting their
capacity to fire to second order cells and decreasing retinal
function. However, changes such as these may not alter the
morphological integrity of the retina.
Figure 6. In vivo identification of gene targets by NR1D1 and NR2E3 in the developing and adult retina. Chromatin
immunoprecipitation was conducted with Nr1d1 and Nr2e3 antibody in the developing (embryonic day 18.5) and adult (postnatal day 30.5)
retina and analyzed by quantitative RT-PCR. Samples were normalized to immunoglobulin (Ig) control precipitation. X axis: expression relative to Ig.
Input: positive control, Nr1d1 B6: NR1D1 ChIP in B6 retina, Nr2e3 B6: NR2E3 ChIP in B6 retina, Rd7: NR2E3 ChIP in rd7 retina (negative control). n=3.
Data values normalized with reference to chart axis.
doi:10.1371/journal.pone.0017494.g006
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NR1D1 in the regulation of photoreceptor gene expression.
Previous in vitro luciferase assay experiments had shown that the
gene complex consisting of CRX/NRL/NR2E3/NR1D1 had a
strong, combinatorial effect in rod-specific gene regulation that
was not apparent when evaluating any single factor [25]. In our
studies, we also observed combinatorial effects of these transcrip-
tion factors and determined that NR1D1 and NR2E3 have dual
roles in the activation and suppression of gene expression.
Consistent with the previously reported suppressor activity of
NR2E3 on cone-specific genes, expression of the cone-specific M-
opsin and Arrestin4 promoters was increased in presence of CRX/
NRL/NR1D1, but NR2E3 ablated or diminished this activity
[26–27]. For the Irbp proximal promoter, which had been shown
previously that binding of NR2E3 was not dependent on the
presence of CRX [27], NR1D1 was more efficient in driving
promoter activity than NR2E3. NR1D1 also acted as a
transcriptional activator on the Rgr proximal promoter, suggesting
a more general role for NR1D1 in transcriptional activation of
photoreceptor gene expression. In the heterologous cell transacti-
vation studies, NR1D1 and NR2E3 activated the expression of the
Rhodopsin promoter and highly potentiated CRX/NRL-driven
activity. However, we did not identify NR2E3 targeting to the
upstream regulatory region of Rhodopsin at the onset of Nr2e3
expression in vivo. This could indicate that NR2E3 does not
regulate the expression of Rhodopsin at embryonic day 18.5, but
may at later time points. On the other hand, and based on
previous studies [25], this also suggests that transcriptional
regulation by NR2E3 is at least in part independent of binding
to target promoters. Taken together, our studies demonstrate that
interaction of transcription factors can have highly variable effects
in the activation or suppression of gene expression depending on
the regulatory region. Whereas NR1D1 preferentially activates
gene expression, NR2E3 was able to both repress and activate
gene expression. The presence of co-factors and additional
transcription factors further modulate gene expression.
Our earlier studies with NR2E3 chromatin immunoprecipita-
tion at postnatal day 2.5 indicated that NR2E3 targets a large
subset of genes critical for photoreceptor development and
function [29], suggesting gene regulation is dynamic during
development. We observed that during development NR1D1 and
NR2E3 co-targeted genes involved in phototransduction, signaling
and transcription, indicating that both genes have the capacity to
modulate genes important for retinal development. For example,
during development, NR1D1 and NR2E3 co-targeted Recoverin
(Rcvn), a calcium binding protein that has a critical role in the
Figure 7. Transactivation assays on putative promoter and
enhancer sequences. HEK293T cells were transiently transfected with
luciferase reporter constructs containing proximal promoter or
enhancer (response elements denoted as RE) regions of Rgr, Rarres2,
Nupr1, Irbp, Arrestin4 (previously called cone arrestin 3), M-opsin, and
Rhodopsin (see Material and Methods). Transfection experiments were
performed in 12-well plates, with 500 ng of luciferase reporter plasmids
and 30 ng of expression vectors for NR2E3 (E3), NR1D1 (D1), CRX (C)
and NRL (N) added per well. To obtain equal amounts of transfected
DNA, appropriate amounts of the pcDNA3.1 plasmid (empty) were
added. Luciferase activity was normalized to beta-galactosidase activity.
Results are expressed as means 6 SEM (n=12–16). For samples
containing both CRX and NRL, columns are colored in grey. Statistical
significance of a two-tailed unpaired t-test are shown as: *: p,0.05;
**: p,0.01; ***: p,0.001. If not indicated otherwise with horizontal
bars, statistical significance is relative to the empty control sample. For
clarity of the histograms, the significant induction of all luciferase
reporter constructs in presence of both CRX and NRL is not indicated.
doi:10.1371/journal.pone.0017494.g007
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targeting of this gene indicates that NR1D1 and NR2E3 could
suppress the expression of Rcvn in developing cone cells, and may
explain why mice lacking Nr2e3 develop hybrid cones that
aberrantly express rod genes [43]. In the adult retina, genes co-
targeted by NR1D1 and NR2E3 were involved in phototransduc-
tion and cell growth, suggesting that improper regulation of genes
involved in these pathways could cause the increase in blue cone
population observed in Nr2e3
rd7/rd7 mice.
Pathways involving phototransduction, signaling, development
and cell growth are major developmental networks within the
retina, and mutations in nuclear receptor genes regulating these
pathways can have far reaching significant consequences.
Although no human mutations in NR1D1 have yet been reported
in association with retinal degeneration, few studies have
examined patients for mutations in this gene [44]. Examination
of more patient cohorts may find mutations in NR1D1 associated
with retinal disease. Our studies identified a role for Nr1d1 in gene
regulation, as well as in the disease process. More studies will be
needed to determine additional factors associated with the
NR1D1/NR2E3 complex, as well as the dynamic gene regulation
occurring in the developing and adult retina.
Methods
Ethics Statement
The mice used in this study were bred and maintained under
standard conditions in the research vivarium at the University of
Nebraska Medical Center under protocol number 04–086
approved by the Animal Care and Use Committee at the
University of Nebraska Medical Center. Mice were housed in
microisolator cages and provided with food and water ad libitum.
The University of Nebraska Medical Center is in compliance with
NIH policy on the use of animals in research (Animal Welfare Act
P.L. 89–544, as amended by P.L. 91–679 and P.L. 94–279) and
the Guide for Care and Use of Laboratory Animals, NIH
Publication number 86-23. Tissues were harvested from B6.Cg-
Nr2e3
rd7/rd7 (rd7) and C57BL/6J (B6) mice at embryonic day 18.5
and postnatal day 30.5. A minimum of 3 Nr2e3
rd7/rd7 and three B6
mice were analyzed for each time point. Mice were genotyped for
the Nr2e3
rd7/rd7 mutation and phenotyped by indirect ophthal-
moscopy for retinal spotting as previously described [13,45].
Western Blotting
Four eyes, enucleated from B6 mice age P30.5, were dissected
and retinas were homogenized in RIPA buffer (1XTBS, 1% NP-
40, 0.5% Na deoxycholate, 0.1% SDS, 0.04% Sodium azide,
1 mM PMSF). Sample concentrations were determined using the
Bradford assay, and 40 mg of protein was loaded onto 4–12%
gradient NuPAGEH Bis-Tris precast gels (Invitrogen). Western
blot transfers were blocked in Odyssey Blocking Buffer (LI-COR)
for 1 h at room temperature with rotation. Blots were incubated
over night at 4uC with Nr1d1 antibody (Sigma, mouse, 1:1000) in
1:1 buffer and 1X PBS. Blots were incubated with beta actin
antibody (Santa Cruz Biotechnology, goat polyclonal, 1:1000) the
following morning for 1 h at room temperature. Secondary
antibodies (Alexa Fluor mouse 680 from Invitrogen, IR Dye
800CW from Rockland) were incubated at 1:10,000 dilution for
1 h in 1:1 buffer and 1XPBS. Blots were developed using the
Odyssey system.
Immunohistochemistry
Eyes were collected, processed and immunohistochemistry was
performed on 10 mm Tissue-Tek OCT embedded sections or
5 mm paraffin embedded sections from B6 and rd7 eyes as
previously described [24]. Sections were incubated with the
following primary antibodies and conditions: Nr1d1 (mouse,
1:1000, Sigma, unfixed and paraformaldehyde fixed OCT
embedded), Nr2e3 (goat, 1:100, Haider lab, unfixed OCT
embedded), Chx10 (sheep, 1:400, Chemicon, paraformaldehyde
fixed OCT embedded), Blue opsin (rabbit, 1:200, Millipore, 1:3
methanol:acetic acid fixed, paraffin), Green opsin (rabbit, 1:200
Millipore, 1:3 methanol:acetic acid fixed, paraffin), Rhodopsin
(mouse, 1:500, Chemicon, 1:3 methanol:acetic acid fixed,
paraffin), Parvalbumin (rabbit, 1:200, Abcam, 1:3 methanol:acetic
acid fixed, paraffin), Calbindin (rabbit, 1:1000, Chemicon, 1:3
methanol:acetic acid fixed, paraffin), and Brn3a (rabbit, 1:400,
Abcam, 1:3 methanol:acetic acid fixed, paraffin) at 4uC overnight.
Images were visualized and collected on a Zeiss Axioplan II
fluorescent microscope as described previously [29].
Cloning of mouse NR1D1 shRNA vectors
A distinct 19-nucleotide shRNA sequence against mouse Nr1d1
was generated, using the small interference RNA selection program
of the Whitehead Institute (http://jura.wi.mit.edu/bioc/siR-
NAext/home.php). LVmNr1d1Aforward and LVmNr1d1Areverse
oligonucleotides for the construct were incubated at 100uC for
15 min and annealed by cooling to roomtemperature. Ligation was
done in the presence of 100 ng of annealed oligonucleotides, and
10 ng of the pLVTHM lentiviral vector cut with MluI and ClaI (a
kind gift from Dr. Didier Trono, Lausanne, Switzerland). To limit
recombination of homologous plasmid sequences, bacterial trans-
formation was done in HB101 cells. Bacterial colonies were
screened by PCR using primers LVscreenfor and LVscreenrev,
resulting in an amplified fragment of 271 bp in the empty
pLVTHM plasmid and 325 bp in the shNr1d1 construct. Positive
clones were verified by sequencing with primer LVscreenfor. An
shRNA sequence directed against crystallin Aa was used as a
control.
In vivo electroporation
Eyes of postnatal day 0.5 B6 mice were subretinally injected
with 1 mg of shNr1d1, shCryaa, or empty vector and in vivo
electroporation was performed as described previously [46–47]
(n.20). Plasmid DNA diluted in sterile H2O was pulse
electroporated into the retina at 80 volts. Mice were aged to
postnatal day 30.5 and phenotyped by indirect ophthalmoscopy,
electroretinogram, hematoxylin and eosin staining, and immuno-
histochemistry as described previously [24]. Uninjected B6 mice
were used as a control in electroretinogram experiments as ERGs
are unaffected by plasmid DNA and procedure [48].
Microarray analysis
RNA was isolated at E18.5 and P30.5 from B6 and rd7 mouse
retinas. Briefly, eyes were enucleated and placed in PBS on ice.
Retinas were dissected using a stereo-microscope (Zeiss Stemi SV
11) and RNA was isolated by TRIzolH extraction. A total of 30
retinas were collected from B6 and rd7 mice at similar time points
during the day. Equimolar amounts of RNA isolated from ten
retinas were pooled into three separate pools from both strains and
time point. RNA was hybridized to Mouse 420A 2.0 (Affymetrix,
Santa Clara, CA) chips by the UNMC Microarray Core Facility
according to manufacturer specifications (Affymetrix, Santa Clara,
CA). Data quality was assessed using the affyPLM package for the
R programming language. Consistencies of expression levels were
confirmed by validation across multiple redundant probe sets.
Differential expression analysis was performed using the Linear
Models for Microarray Analysis portion of Bioconductor. Genes
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using a FDR-adjusted p-value of 0.001 and at least a 2-fold change
were combined and used to perform clustering analysis. A self-
organizing map (SOM) clustering algorithm was applied to genes
showing significant expression differences as judged by mean log2
intensity per strain. The gap statistic was used to estimate the
optimal number of clusters. Additional analysis was performed
using BRB Array Tools for Excel 2007, as well as the Stanford
Statistical Analysis of Microarrays (SAM) plug-in for Excel 2007.
Microarray results were confirmed by quantitative RT-PCR.
Quantitative (real time) RT-PCR
Total RNA was isolated from embryonic day 18.5 and postnatal
day 30.5 pairs of eyes from rd7 and B6 mice using TRIzolH and
samples testing positive by DNA microarray were confirmed by
quantitative RT-PCR. To generate an expression profile for Nr1d1
and Nr2e3, quantitative RT-PCR was performed with samples
collected at 1 pm for the following time points: embryonic day (E)
10.5, E12.5, E14.5, E16.5, E18.5, postnatal day (P) 0.5 P2.5, P6.5,
P10.5, P21.5 and P30.5. Gene expression studies over a twenty-
four hour period were performed with retinal lysates from B6 adult
(1–3 months) mice collected every four hours (12 am, 4 am, 8 am,
12 pm, 4 pm, 8 pm). Sample preparation, quantitative RT-PCR
reaction and analysis were performed as described previously [29].
Primers are listed in Table S1.
Chromatin Immunoprecipitation
Potential gene targets identified through subtractive hybridization
[29] and microarray studies, were searched for classic nuclear
receptor response element binding sites. Binding sites consisted of the
homologous sequence ‘‘AAGTCA(n1–4)AAGTCA’’with less than two
base pair alterations from the consensus (or binding sites identified in
our previous studies [29]) were selected at a maximum distance of
30 kB upstream of the ATG start site. Sixty seven genes were
identified as containing testable response elements, and chromatin
immunoprecipitation was performed on these putative gene targets,
as described previously [29], using embryonic day 18.5 and postnatal
day 30.5 retinas from B6 and rd7 mice. Immunoprecipitation was
performed overnight with 1mg of Nr1d1 antibody (Sigma), Nr2e3
antibody (Haider lab) or preimmune Ig antibody (R&D Systems). Rd7
retinal tissue was immunoprecipitated with Nr2e3 antibody as a
negative control. Quantitative RT-PCR was performed using 1mlo f
1:100 dilution (Input) and 1:10 dilution (samples and Ig G control)
using conditions described previously [49]. All sample data was
normalized to Ig control. Primers are listed in Table S1.
Luciferase assay
Mouse proximal promoter regions or upstream regulatory regions
(RE) surrounding a consensus nuclear receptor response element
were subcloned into KpnI/BglII or SacI/BglII sites of the pGL2-
promoterluciferasereportervector(Promega)forthefollowinggenes:
Rgr, Rarres2, Nupr1, Irbp,a n dArrestin4. Primers are listed in Table S1.
M-opsin and Rhodopsin promoter constructs were obtained from Dr.
Shiming Chen [27]. Full-length mouse Nr1d1 and human Nr2e3
cDNA were cloned into the pcDNA3.1/HisC vector (Invitrogen). All
constructs were verified by sequencing on an ABI 3130xl Genetic
A n a l y z e ru s i n gt h eB i gD y eT e r m i n a t o rL a b e l i n gK i t( A p p l i e d
Biosystems, Carlsbad, CA). For transactivation assays, human
embryonic kidney (HEK) 293T cells were grown at 37uCa n d5 %
CO2 in Dulbecco’s modified Eagle’s medium (DMEM) (PAA
Laboratories GmbH, Pasching, Austria) supplemented with 10%
fetal calf serum (FCS), 100 U/ml pen and 100 mg/ml strep
(Invitrogen AG, Basel, Switzerland). Cells were plated in 12-well
plates (TPP, Trasadingen, Switzerland) and transfected at a
confluence of 30% with the Calcium Phosphate method (ProFec-
tionH, Promega, Madison, WI). Per well, 30 ng of each of the
expression vectors (pcDNA3.1/HisC-hNR2E3, pcDNA3.1/HisC-
mNR1D1, pcDNA3.1/HisC-hCRX and pMT-hNRL) were used,
together with 500 ng of the above-mentioned luciferase reporter
constructs. As internal standard, 33 ng of plasmid CMVb (Clontech,
Mountain View, CA) encoding b-galactosidase was used. To keep the
total transfected DNA quantity constant, appropriate quantities of
pcDNA3.1/HisC empty vector were added in all experiments. All
plasmids were prepared on NucleoBondHPC500 columns (Ma-
cherey-Nagel, Du ¨ren, Germany). Enzymatic activities were assessed
with Luciferase Assay System (Promega) and standard b-Gal assay.
Statistical analysis (two-tailed unpaired t-test) was performed with
Prism 4.0.2 (GraphPad Software Inc., La Jolla, CA).
Efficiency of shNr1d1
To test the efficiency of the short hairpin (sh) RNA vector in
silencing mouse (m) Nr1d1 expression (Figure S1), HEK293T cells
were transiently transfected in 100-mm plates at a confluence of
30% with 2mg of pcDNA3.1-mNr1d1, a mammalian expression
vector for mouse Nr1d1. Additionally, 2mg of either pLVTHM
empty vector, or pLVTHM encoding a shRNA for mNr1d1
(shNr1d1) or crystallin Aa (shCryaa) were co-transfected. After 48 h
of transfection, the transfection efficiency was estimated under a
fluorescent microscope (Zeiss Axiovert 200) with a 20x objective, by
counting the number of cells expressing the co-transfected pnlsGFP
(100 ng/dish) [50]. Four regions were counted and average values
used as a normalisation factor. Total RNA was then extracted with
TRI ReagentH (Molecular Research Center Inc., Cincinnati, OH)
according to manufacturer’s instructions. Total RNA was treated
with DNAse I (Applied Biosystems/Ambion, Austin, TX). Reverse
transcription was performed on 500 ng of total RNA (1st strand
cDNA synthesis kit for RT-PCR (AMV); Roche, Basel, Switzer-
land). Quantitative PCR was performed on an Mx3000p sequence
analyzer (Stratagene, La Jolla, CA) using Fast Start Universal
SYBRHGreen Master Mix (Rox) (Roche). To assess mouse Nr1d1
expression, primers mNr1d1for and mNr1d1rev were used. As
internal standard, Gapdh expression was assessed with primers
hGapdhfor and hGapdhrev (for primer sequences see Table S1).
Statistical analysis was performed with Prism 4.0.2 (GraphPad
Software Inc., La Jolla, CA).
Supporting Information
Table S1
(XLS)
Figure S1 Efficient silencing of mouse Nr1d1 expres-
sion. In human HEK293T cells transiently expressing mouse
NR1D1 (mNr1d1), a short hairpin RNA (shRNA) construct
targeting mNr1d1 mRNA (shNr1d1), decreased relative mRNA
levels by about 30% (p=0.0051). A control shRNA sequence
directed against crystallin Aa did not interfere with mNr1d1
mRNA expression (p=0.0838). Results correspond to three
independent transfections in duplicates. Statistical significance
was tested with a two-tailed paired t-test.
(DOC)
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